Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Non-Current Assets: 2013-2019

Historic Non-Current Assets for Soleno Therapeutics (SLNO) over the last 5 years, with Sep 2019 value amounting to $17.1 million.

  • Soleno Therapeutics' Non-Current Assets fell 11.87% to $17.1 million in Q3 2019 from the same period last year, while for Sep 2019 it was $17.1 million, marking a year-over-year decrease of 11.87%. This contributed to the annual value of $18.5 million for FY2018, which is 12.11% down from last year.
  • Latest data reveals that Soleno Therapeutics reported Non-Current Assets of $17.1 million as of Q3 2019, which was down 2.30% from $17.5 million recorded in Q2 2019.
  • In the past 5 years, Soleno Therapeutics' Non-Current Assets ranged from a high of $22.1 million in Q1 2017 and a low of $44,000 during Q1 2015.
  • Its 3-year average for Non-Current Assets is $19.5 million, with a median of $20.0 million in 2017.
  • As far as peak fluctuations go, Soleno Therapeutics' Non-Current Assets surged by 4,006.82% in 2016, and later dropped by 12.55% in 2019.
  • Over the past 5 years, Soleno Therapeutics' Non-Current Assets (Quarterly) stood at $1.8 million in 2015, then decreased by 1.86% to $1.8 million in 2016, then surged by 1,092.36% to $21.0 million in 2017, then decreased by 12.11% to $18.5 million in 2018, then dropped by 11.87% to $17.1 million in 2019.
  • Its last three reported values are $17.1 million in Q3 2019, $17.5 million for Q2 2019, and $18.0 million during Q1 2019.